Patients with acute kala azar are generally nonreactive in a number of immunologic assays, including T cell proliferation and generation of macrophage-activating cytokines, principally IFN-'y, in response to leishmania antigens in vitro. To test for potential immunosuppressive factors, a series of T cell lines and clones were established from patients with acute kala azar, from patients after chemotherapy for kala azar, and from skin test-positive adults from the same endemic region. Although CD4+ T cell lines and clones could be readily established from the skin test-positive adults, lines and clones from acute or treated patients were heavily biased in expression of CD8+. The CD8 + cells from acute patients did not themselves release cytokines in response to leishmania antigens in vitro, but markedly affected the cytokine profile of peripheral blood mononuclear cells isolated 1 yr later after recovery. Addition of the CD8 + cells caused inhibition of lymphoproliferation and IFN-y release, with augmentation of IL-6 and IL-10 release. The inhibitory effects of the CD8+ cells could be partially abrogated by antibodies to IL-10 but not by antibodies to IL4. Analysis of four patients with acute kala azar demonstrated release of IL-10 that could not be demonstrated in supernatants from asymptomatic skin test-positive individuals. Generation of IL-10 may contribute to the profound suppression of IFN--y release that occurs during kala azar due to Leishmania chagasi. (J. Clin. Invest. 1993. 92:2626-2632.) Key words: leishmania -interleukin-10 * kala azar * interferon-'y -immunosuppression
Introduction
Leishmania infection produces a spectrum of illness that depends both upon the species of the infecting organism and the host immune response. Cellular immunity capable of activating host macrophages, the only cell known to support growth of the intracellular forms of leishmania, is felt to be critical for successful eradication of the parasite. Peripheral blood lymphocytes taken from patients with visceral leishmaniasis, or kala azar, proliferate poorly and release little IFN-'y in response to parasite antigens in vitro ( 1-3), and do not activate infected macrophages to a leishmanicidal state (2) . In contrast, lymphocytes taken from individuals with delayed-type skin reactions to leishmania antigens who remain asymptomatic despite residence in highly endemic areas proliferate and release IFN-,y in vitro ( 1, 2) and activate their autologous infected macrophages to a leishmanicidal state (2) . Such findings have encouraged the successful use of IFN-y in refractory kala azar (4) , although the basis for these underlying immune responses remains obscure.
In murine leishmaniasis produced by Leishmania major, counter-regulation between protective T helper type 1 (Th 1)1 CD4' cells that release IFN-y and nonprotective Th2 CD4' cells that release IL-4 and IL-10 has been suggested by several investigators (5, 6) . Although IFN-'y release from lymphocytes taken from patients with solid immunity to leishmania has suggested the occurrence of protective Th 1 CD4+ cells in humans, it has been more difficult to establish a role for Th2-like cells during acute disease in humans with kala azar ( 1-3) or mice infected with L. donovani (7) . In this report, we characterized T cell lines and clones taken from patients with acute kala azar, patients studied after therapy with antimonials, and normal skin test-positive adults in order to test for the presence of potential immunosuppressive factors in human visceral leishmaniasis.
Methods
Human subjects. Six patients representing the spectrum of clinical responses to L. chagasi infection were studied. Informed consent was obtained in accordance with institutional guidelines at each of the participating universities. All were from the state of Ceara in northeastern Brazil, where kala azar is endemic (8) . Two adults males, 17 and 39 yr old (designated D4 and D5), were skin test positive to L. chagasi antigens using reagents and criteria previously described (8) . Peripheral blood lymphocytes from both men proliferated and released IFN--y in response to L. chagasi antigens in vitro, and activated autologous infected macrophages to kill intracellular amastigotes in vitro (2) . Neither had any signs or symptoms attributable to L. chagasi infection at the time of study or had any history of kala azar. Two adult males, 17 and 33 yr old (designated R2 and R8), were treated for kala azar upon presentation with typical signs and symptoms and demonstrable amastigotes in biopsies of bone marrow. Both received 20 d of therapy with pentavalent antimony (20 mg/kg per d) and neither required retreatment. Cells were collected within 6 mo after completion of therapy. One ofthe men (R8) was completely free ofsymptoms. The other (R2) had residual splenomegaly and intermittent fatigue without fever. PBMC from both R2 and R8 failed to secrete IFN-'y in response to L. chagasi antigens but their peripheral blood T cells were able to activate autologous macrophages to kill amastigotes (2) . Two adult males, 17 and 33 yr old (designated P1 and P2), had cells collected for study 7 and 12 d after the initiation of pentavalent antimony therapy for acute kala azar diagnosed by signs and symptoms and the presence ofamastigotes in bone marrow aspirates. PBMC from P1 and P2 failed to secrete IFN--in response to L. chagasi antigens, and their peripheral blood T cells were unable to activate autologous macrophages to kill amastigotes (2) . These same patients were studied again 1 yr later at a time when both were entirely well and free ofall signs and symptoms ofkala azar.
Isolated PBMC were prepared as described (2) from seven patients with acute kala azar, four patients who had completed therapy with antimonials 2 wk to 6 mo before the study, and two skin test-positive asymptomatic adults from the endemic area. Washed PBMC were suspended in Iscove's modified Dulbecco's medium containing 20% human AB serum and antibiotics with or without 20 ,g/ml L. chagasi antigens prepared as described (2) . In designated experiments, 3 X 106 washed PBMC were mixed with 1 qg/ml murine anti-human CD8 mAb (Caltag Laboratories, South San Francisco, CA) for 30 min at 4°C, washed, and further incubated with 4 X 107/ml goat anti-mouse IgG-coated magnetic beads (Advanced Magnetics, Inc., Cambridge, MA). A magnetic separator (Advanced Magnetics, Inc.) was used to retain antibody-bound cells while collecting unbound cells. The procedure was repeated twice and the numbers of remaining CD8 + cells in the unbound cell population were quantitated by FACSO (Becton Dickinson & Co., Mountain View, CA) analysis after incubation with anti-mouse FITC-conjugated anti-human CD8 mAb (Caltag Laboratories). The CD8-depleted cells were assayed using comparable cell numbers as with total PBMC. Supernatants were collected after 72 h and frozen before assaying for IL-lO (below) .
Parasites andparasite antigens. L. chagasi promastigotes were cultured in HOSMEM II medium (9) containing 20% FCS and harvested from stationary phase cultures by centrifugation before use.
Establishment of T cell lines and clones. PBMC collected as described (2) were washed twice in HBSS (GIBCO BRL, Gaithersburg, MD) containing 0.25% BSA and cultured at 4 X 106 cells/ml in Iscove's modified Dulbecco's medium (GIBCO BRL) containing 20% human AB-positive serum, penicillin/streptomycin (GIBCO BRL), and 20 pg/ml L. chagasi antigens at 37°C in 5% CO2, air for 2 wk.
Subsequent expansion used one of two methods depending upon the availability of frozen autologous cells and the extent ofantigen-specific proliferation after the initial 2-wk period.
The first method was used for both skin test-positive patients (1D4 and D5) and one ofthe recovered patients (R2 5 and collected using a multiple sample harvester on day 6 for scintillation counting. Cultures of T cells alone were incubated with 10 ng/ml PMA and 250 ng/ml ionomycin (Sigma Chemical Co.) in the presence or absence of 25 U/ml rIL-2, and the supernatants were collected on days 1 and 3 for lymphokine assays.
IFN-y, IL-4, IL-6, and IL-10 were assayed using monoclonal-based immunoenzymatic ELISA as described (2, 13, 14) . These assays are sensitive to 40-100 pg/ml. Lymphotoxin (LT) was assayed using the WEHI-164 bioassay as described (15 Designated T cell clones were evaluated for NK activity using the K562 cytotoxicity assay as described ( 16) . Briefly, 5 x 103 5'Cr-labeled K562 cells were incubated with 5.0, 2.5, or 1.2 X 104 T cells in a volume of 200 ,l of medium for 4 h before assaying for chromium release.
Statistics. Analysis of variance was used to determine the significance of differences between means collected from the designated groups.
Results
Analysis of T cell lines and clonesfrom skin test-positive individuals. 70 clones were isolated from subject D4, and 20 were isolated from subject D5. The latter and 20 of the fastest growing D4 clones were analyzed for CD4 and CD8 expression; all of the D5 and 19 (95%) of the D4 clones were a/3 TCR+,CD4+,CD8- (Fig. 1 A) . The remaining D4 clone was CD8 + ,CD4-. Polyclonal D4 and D5 T cell lines maintained by PHA stimulation became 100% CD4+,a/f TCR+ after two cycles of stimulation (Fig. 1 B) . The clones displayed a range of leishmania-specific IFN-'y secretion from 0 to 1.5 ng/ml for D4 clones and 0 to 8.0 ng/ml for D5 clones. Similarly, the leishmania-specific LT responses varied from 0 to 480 U/ml for D4 clones and 0 to 310 U/ml for D5 clones. None of the clones secreted IL-4 or IL-10. 11
clones secreted > 1 ng/ ml of IFN-,y in response to leishmanial antigens (Table I) . Designated clones from D4 and D5 were assayed for their ability to activate autologous macrophages to kill intracellular amastigotes (Table II) . All of the clones that secreted significant quantities of IFN--y were able to activate macrophages to kill > 99% of intracellular amastigotes as assessed microscopically. Most of the clones also displayed either cytotoxicity or inhibition of adherence by macrophages, since the infected Characterization of T cell lines and clones from recently treated patients. 70 clones were isolated from patient R2, of which 11 were analyzed for expression ofCD4 and CD8. Eight (73%) of the clones were CD4+,CD8 -and three (27%) were CD4-,CD8'. Seven clones were isolated from patient R8, of which five (71%) were CD4',CD8-and two (29%) were CD4-,CD8'. Both polyclonal R2 and R8 T cell lines maintained by PHA stimulation became 90-1 00% CD8 + after three to four rounds of stimulation and rest (Fig. 1) (Table III) . 14 P1 and 18 P2 clones were assayed, as well as the polyclonal lines 10/90 and 1/91; all were found to inhibit PBMC proliferative responses to parasite antigens. No IL-4 was detected in any of the supernatants. All P2 clones and the polyclonal P2 10/90 line suppressed leishmania antigen-specific IFN-,y secretion and proliferation, and increased IL-6 and IL-10 secretion. P1 clones were generally less active than P2 clones, but also suppressed leishmania antigen-specific proliferation and IFN-'y secretion, and increased IL-6 secretion (data not shown). P2 10/90 had no effect on proliferation to tetanus toxoid or candida antigens (data not shown). Shown is one of two comparable experiments.
Interleukin-IO in Visceral Leishmaniasis
The polyclonal CD8 + T cell line, P2 10/90, was chosen for further study because it was easily maintained in culture and was more active in the previous assays (Table IV) . The addition of the P2 10/90 CD8 + cell line from the same patient 1 yr earlier caused a marked reduction in the amount of IFN-'y recovered together with a fivefold increase in IL-1O. Addition of anti-IL-10 completely restored the IFN-,y response. Addition of anti-IL-4 had little effect in this assay, although an increase in IL-10 levels with a concomitant decrease in IFN-y was detected. IL-4 was undetectable in these experiments.
IL-OI secretion by PBMC. The suggestion that IL-10 might be involved in some of the immunomodulation by the CD8+ lines in vitro prompted studies using freshly isolated cells. PBMC from patients in each of the study groups were stimulated in vitro with L. chagasi antigens for 72 h and the supernatants quantitated for IL-10 using ELISA (Fig. 2) . All four patients with acute kala azar had readily detectable levels of IL-10; one of these patients had detectable levels in cultures maintained in the absence of antigen (1.32 ng/ml). Patients studied during the 6 mo after therapy with glucantime had detectable but lower IL-10 levels, whereas the two skin test-positive adults had no antigen-dependent release of IL-10. The differences between the levels released by patients with acute kala azar and the other groups was significant (P < 0.05).
The capacity of CD8 + cells lines isolated during acute kala azar to augment IL-10 production from cells isolated after recovery suggested that CD8+ T cells may be mediating IL-10 production during acute disease. Three patients with biopsyproven kala azar had PBMC isolated and aliquots were depleted of CD8 + T cells using antibody coated-magnetic beads. Bead-treated cells consisted of 1-6% CD8 + cells, as compared with 14-23% CD8+ cells in the unfractionated PBMC. After stimulation, supernatants were assayed for IL-IO. In two cases, IL-10 levels increased after CD8+ depletion (from 0.8 to 1.7 and 0.9 to 1.4 ng/ml for antigen-stimulated release); in the third, IL-10 levels were comparable under both conditions. Discussion L. chagasi infection constitutes a spectrum from acute kala azar to asymptomatic skin test conversion believed to depend upon the immune response of the host. A number of studies have documented the correlation between the capacity of PBMC to generate macrophage-activating factors, particularly IFN-,y, after stimulation with parasite antigens in vitro and immunity to infection. Conversely, PBMC from patients with acute kala azar are unable to generate IFN-y in vitro (1) (2) (3) or to activate autologous infected macrophages to kill intracellular amastigotes (2) . These studies demonstrate the ability to clone CD4+ cells ofthe Th 1-like phenotype from immune individuals. Although IFN-'y was not recovered from stimulation of PBMC taken from patients with kala azar, these supernatants, unlike those from immune skin test-positive individuals, contained IL-10. Establishment of T cell lines from acute patients consistently yielded CD8 + lines and clones that had the capacity to abrogate parasite-specific proliferation and IFN-'y production when added back to autologous cells 1 yr later. The diminished IFN-'y release in the presence of CD8 + cells could be reversed by the addition of neutralizing IL-1O antibody. Together, these data support a possible role for IL-10 in mediating the immunosuppression of acute kala azar and suggest complex interactions between CD8+ and CD4' cells in determin- ( 17) and L. donovani ( 18) . These studies together with a number of investigations of murine L. major infection (5, 6) have established the central role for CD4 + Th 1 cells in elaboration of macrophage-activating factors implicated in eradication of the parasite ( 19) . As noted by others ( 17, 18) , cloning of human cells by the methods used led to an outgrowth of CD4' cells that was readily maintained in culture. Although most of the macrophage-activating clones also released IFN-'y and LT, this was not an invariant response, suggesting other mechanisms, including cytotoxicity (20) , might underlie host defense against leishmania.
Unexpected was the outgrowth of CD8+ lines and clones from PBMC taken from patients with kala azar after culture in vitro. Similarly, cells taken from patients recently treated for kala azar developed a marked bias for CD8 + with time in culture. Proliferation and cytokine release by the CD8 + lines and clones were not consistently observed, raising concern regarding the antigen specificity of these cells. Despite being generated using allospecific and EBV-transformed cells, no cytotoxicity against alloantigens or EBV-infected targets could be demonstrated. The best evidence suggesting the leishmania reactivity of these lines was generated with lines P1 and P2; each had profound antigen-specific effects on autologous PBMC taken from the donors 1 yr later when Th 1-like responses could be demonstrated. The reason underlying the preferential outgrowth of CD8 + cells in the in vitro cultures from acutely infected patients, however, remains unknown. Others have similarly noted the difficulty in culturing long-term CD4+ populations from patients with kala azar (3, 18) . As reported here, even sorted CD4+ lines did not release IL-4 or IL-1O after stimulation with PMA and ionomycin in vitro, suggesting that the circulating IL-4 detected in patients with kala azar (2, 21 ) may arise from non-T cell sources (22) or from T cells out of the circulating compartment.
The effects of the P1 and P2 lines and clones on the subsequent activation of autologous PBMC by leishmania antigens suggest novel counter-regulatory systems in visceral leishmaniasis that might account for the profound immunosuppression during acute disease (23) . Addition ofCD8 + lines established at the time of disease to competent PBMC caused abrogation of lymphocyte proliferation and IFN-y release associated with increases in IL-6 and IL-10 release. In the mouse, both IL-6 and IL-10 are released by Th2 cells and various antigen-presenting cell populations, and have been demonstrated to deactivate macrophages (24, 25) , the target cell for leishmania. In human studies, IL-10 is produced by ThO, Th 1, and Th2 cells ( 14, 26) , as well as keratinocytes (27) and antigen-presenting cells, including macrophages and B cells (28) . Increases in IL-6 and IL-10 and a decrease in IFN-y would be expected to profoundly interfere with the capacity ofthe infected macrophages to be activated to kill amastigotes. How these CD8 + cells mediate these effects is unclear, although antibodies to IL-10 restored IFN-y production. The CD8 + cells themselves did not consistently release IL-4 or IL-10, and depletion of CD8 + cells before generation of IL-IO from PBMC in vitro yielded an increased amount of IL-10, rather than the decreased amount that might have been expected if these cells directly mediated IL-10 production. Together, these experiments suggest complex interactions between the regulatory T cells and antigenpresenting cells that determine the ultimate proliferative and cytokine profile of the mixed culture. Similar observations were recently reported in studies of lepromatous and tuberculoid leprosy (29) , suggesting that Th2-like regulatory functions may not be unusual features of CD8 + cells that appear during acute progressive infectious diseases. The CD8 + cells analyzed here were consistently al/3 TCR',CD56',CD57-, suggesting that a particular phenotype may be associated with the functional effects noted.
The capacity for cells from acutely ill patients to suppress immunospecific responses caused us to examine the supernatants from stimulated PBMC from each of the patient groups. In prior experiments we had been unable to recover IL-4 from acute patients' cells, although one-third ofthese patients, as in a prior report (21 ) , had IL-4 recovered from sera by ELISA (2). In the experiments reported here, PBMC from acute patients released readily detectable IL-10 into the media, whereas cells from treated patients released less IL-10, and cells from skin test-positive individuals released no antigen-specific IL-10. A recent study further documents the capacity to recover IL-10 cytokine transcripts from bone marrow aspirates of patients with kala azar (30) . These data suggest that the triggering of IL-4 and IL-10 release during acute infection may contribute significantly to the measured suppression ofIFN-y release, and contribute to the progressive nature of disease. The possibility remains that IL-10 may be released by infected macrophages and may contribute to the abrogation ofIL-1 and TNF generation by these cells (31 ) .
The spectrum ofresponse to leishmania has similarities to a number ofother infectious diseases. Indeed, CD8 + suppression in the lepromatous type of leprosy has been associated with production of Th2-like cytokines by these cells (29) . As additional investigations establish these biased cytokine-mediated responses in a number of infectious diseases, the challenge will remain to determine the mechanisms that lead to the initial maturation ofeffective or ineffective T cell responses. The data reported here suggest that counter-regulatory mechanisms between both CD4 and CD8 cells may contribute to the marked bias in the immune response associated with leishmaniasis.
